Author:
Skwiersky Samara,Iwuala Sandra,Chillumuntala Seeta,Osafehinti Deborah,Karam Jocelyne
Abstract
With its alarmingly rising prevalence worldwide, type 2 diabetes has become a leading cause of morbidity and mortality around the planet. Efforts to prevent progression to diabetes in individuals at risk could have a significant positive public health impact. Multiple trials examining cardiovascular outcomes of Renin-Angiotensin-Aldosterone System (RAAS) inhibitors revealed, in secondary analysis, a significantly reduced risk of new onset diabetes in participants receiving these agents. This glycemic protective effect is attributed to the known implication of RAAS in the development of insulin resistance and type 2 diabetes. The DREAM trial and the NAVIGATOR trial were two large randomized controlled studies examining, as primary outcome, the effect of Ramipril and Valsartan respectively on the incidence of diabetes in patients with prediabetes. Their results confirmed a favorable glycemic effect of RAAS inhibition agents and suggested a possible added benefit of diabetes prevention to their other several cardiovascular and blood pressure benefits.
Reference53 articles.
1. Diabetes and the Eye: Latest Concepts and Practices. Diabetes: Current and Future Developments. Vol. 2. 2021, Singapore: Bentham Science Publishers Pte. 249
2. Yip, W.C.Y., et al., Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia. Nutrients, 2017. 9(11): p. 1273
3. Cho, N.H., et al., IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice, 2018. 138: p. 271-281
4. Organization, W.H. Diabetes Fact Sheet. 2020 [cited 2021 February 24, 2021]; Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
5. Kannel, W.B. and D.L. McGee, Diabetes and cardiovascular disease. The Framingham study. Jama, 1979. 241(19): p. 2035-8
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献